HEIDI LEIMKUEHLER: Open Payments
NPI 1750043725 · CARROLLTON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$287 in 15 payments from 11 companies in 2025. Trend: 2023 $333 · 2024 $457 · 2025 $287
Food & beverage: $287
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $75 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $30 |
| SANOFI-AVENTIS U.S. LLC | 1 | $28 |
| Dexcom, Inc. | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $16 |
| Janssen Pharmaceuticals, Inc | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
Products named: VRAYLAR, AIRSUPRA, TZIELD, Dexcom G6 Transmitter, ABILIFY ASIMTUFII, CAPLYTA, JOURNAVX, QULIPTA.
Industry payments across MO — which companies pay providers there.
